Abstracts tagged "drug safety monitoring and quality measures"

Abstract Number: 314 • ACR/ARP Annual Meeting 2019
Pre-treatment Screening for Hepatitis B and C Among Users of Biologics or New Synthetic Disease Modifying Drugs: An Analysis Using RISE Data
Jing Li ¹, Julia Kay ¹, Jinoos Yazdany ¹ and Gabriela Schmajuk², ¹UCSF Division of Rheumatology, San Francisco, CA, ²UCSF, SFVAMC Division of Rheumatology, San Francisco, CA
Background/Purpose: Testing for hepatitis B virus (HBV) and hepatitis C virus (HCV) is recommended for patients initiating biologics or new synthetic DMARDs, which can increase the risk…